Join Gary Hewitt, General Superintendent, as he walks through the Acorda Therapeutics, Chelsea Manufacturing Facility Phase 2 project.


With 35 years of industry experience, Gary has worked on several life sciences projects across the Northeast. Gary and the Acorda Therapeutics project team started work at this manufacturing facility in 2018 and have a completion scheduled for October 2019. The videos below highlight critical aspects of the project.

Project at a Glance


Acorda Therapeutics





Construction Cost

$92 million




Delivery Method



Completion Date

October 2019



Chillers | Process Pumps

Lean Building | Spray Dryer Mechanical Space | Level 5 Drywall Finish |
”Clean” Welded Platform

Pharmaceutical Manufacturing Storage Tanks

cGMP Warehouse | Packaging Rooms | CNC/Grey Corridor

Feed Module Skid

Capsule Fill Rooms | Clean Space and 3 Level Clean Stair

Packaging Rooms | Clean Space

Clean Environment with Glass Wash/Autoclave

Mechanical Space | Spray Dryer | Air Handlers (GMP, non GMP and Desiccant Dryers)

Non GMP and GMP Units | Process Piping Coupon Weld | Utility Piping | Desiccant Dryers | Independent Expansion Joint | High-Bay Rooms | Existing Spray Dryer

Clean Stairs/Service Elevator

For more information about the
Acorda Therapeutics project, you can reach out to:

Tieg Murray

Marketing Manager
Life Sciences COE